Skip to content

Clinical trials

Phase 3 Lung Neoplasms trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 3 Country / region: Czechia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20091
20141
20151
20182
20202
20232
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting7
Active, not recruiting3
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AstraZeneca2
Bristol-Myers Squibb2
Gustave Roussy, Cancer Campus, Grand Paris2
Merck Sharp & Dohme LLC2
Pfizer2
Celgene1
Daiichi Sankyo1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms22
Carcinoma, Non-Small-Cell Lung16
Carcinoma6
Lung Diseases4
Neoplasms4
Small Cell Lung Carcinoma4
Bronchial Neoplasms2
Neoplasm Metastasis2
Neoplasms by Site2
Respiratory Tract Diseases2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.